HH-25 Trademark

Custom manufacture of Organic CBD Oil with a 25:1 CBD:THC ratio by pharmaceutical compounders

Anti-arthritic compositions and preparations; Anti-cancer preparations; Anti-epileptic pharmaceutical preparations; Chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of Epilepsy, Multiple Sclerosis, Cancer, and Parkinson's Disease; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of Organic Botanical Oil that facilitate the delivery of pharmaceutical preparations; Medicinal herb extracts; Medicinal herbal extracts for medical purposes; Medicinal herbal preparations; Medicinal herbs; Medicinal infusions for treating Epilepsy, Multiple Sclerosis, Cancer, and Parkinson's Disease; Medicinal oils; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the prevention of seizures; Pharmaceutical preparations for the treatment and prevention of seizures; Pharmaceutical preparations for the treatment of Epilepsy, Multiple Sclerosis, Cancer, and Parkinson's Disease; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for use in urology; Pharmaceutical preparations for pediatric patients with status epilepticus; Pharmaceutical preparations, namely, elixirs for the treatment of Epilepsy, Multiple Sclerosis, Cancer, and Parkinson's Disease; Pharmaceutical products for the prevention and treatment of cancer; Plant extracts for medical, veterinary and pharmaceutical purposes; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders; Syringes sold filled with Organic CBD Oil with a 25:1 CBD:THC ratio; Syrups for pharmaceutical purposes for the treatment of Epilepsy, Multiple Sclerosis, Cancer, and Parkinson's Disease

Active chemical ingredients for use in the manufacture of pharmaceuticals for treating Epilepsy, Multiple Sclerosis, Cancer, and Parkinson's Disease; Chemical additives for use in the manufacture of Organic CBD Oil with a 25:1 CBD:THC ratio; Preservatives for pharmaceutical preparations